September 2nd 2022
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
September 23rd 2019
FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.
September 19th 2018
The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.
March 16th 2018
Sensors and devices being developed by nGageIT Digital Health Solutions can track patient use of oral solid-dosage or injectable drugs.
October 1st 2017
There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.
Are Oral Peptide Drugs on the Horizon?
A new study examines the oral delivery of protein drugs in plant cells and hypothesizes that the cold storage and transportation of biologics could someday be eliminated.
Novo Nordisk to Start Phase IIIa Trials for Oral Biologic
The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.
FDA Issues Dissolution Testing Guidance
FDA issues draft guidance on dissolution testing for immediate-release solid oral dosage forms.
Almac Adds Contained Drug Handling Capabilities
Almac's Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.